Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
Ryan C Neal, Peter H JonesBaylor College of Medicine, Section of Lipid and Atherosclerosis, Houston, TX, USAAbstract: Cardiovascular (CV) disease remains the number 1 cause of death in the USA. Nonetheless, there has been a decline in the age-adjusted death rate for coronary heart disease (CHD) whic...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Dove Medical Press
2006-03-01
|
| Serie: | Vascular Health and Risk Management |
| Länkar: | https://www.dovepress.com/complementary-therapy-to-target-ldl-cholesterol-the-role-of-the-ezetim-peer-reviewed-article-VHRM |
| Taggar: |
Inga taggar, Lägg till första taggen!
|